| Basics |
BioLife Solutions, Inc.
BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation.
|
| IPO Date: |
October 1, 2002 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$1.05B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.47 | 3.02%
|
| Avg Daily Range (30 D): |
$0.46 | 2.06%
|
| Avg Daily Range (90 D): |
$0.61 | 2.67%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.22M |
| Avg Daily Volume (30 D): |
.46M |
| Avg Daily Volume (90 D): |
.46M |
| Trade Size |
| Avg Trade Size (Sh.): |
76 |
| Avg Trade Size (Sh.) (30 D): |
60 |
| Avg Trade Size (Sh.) (90 D): |
55 |
| Institutional Trades |
| Total Inst.Trades: |
1,340 |
| Avg Inst. Trade: |
$1.56M |
| Avg Inst. Trade (30 D): |
$1.44M |
| Avg Inst. Trade (90 D): |
$1.43M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.59M |
| Avg Closing Trade (30 D): |
$1.61M |
| Avg Closing Trade (90 D): |
$1.59M |
| Avg Closing Volume: |
59.09K |
|
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-.01
|
$-.04
|
$-.45
|
|
Diluted EPS
|
$-.01
|
$-.04
|
$-.45
|
|
Revenue
|
$ 23.94M
|
$ 30.57M
|
$ 28.33M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -.45M
|
$ -1.7M
|
$ -20.72M
|
|
Operating Income / Loss
|
$ -1.22M
|
$ -1.56M
|
$ -2.8M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -28.44M
|
$ 2.08M
|
$ -7.68M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jan 29, 2014:
1:14
|
|
|
|
